RE: Pharma and biotech seek cure for industry deal slump16 Jan 2023 08:00
That's interesting about Merck and a Seagen takeover Seagen being a MaB player and possibly one of Scancells collab partners with deal potential....What a big price tag attached $40 billion phew ,Seagens current Mcap I believe around $24 billion.... Merck willing to pay out the big bucks!
Can't even imagine what a proven commercial modi 1 might be worth to pharma never mind the entire moditope platform